B. Martell

423 total citations
6 papers, 319 citations indexed

About

B. Martell is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, B. Martell has authored 6 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in B. Martell's work include Renal cell carcinoma treatment (4 papers), Cancer Genomics and Diagnostics (3 papers) and Economic and Financial Impacts of Cancer (2 papers). B. Martell is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Cancer Genomics and Diagnostics (3 papers) and Economic and Financial Impacts of Cancer (2 papers). B. Martell collaborates with scholars based in United States, Canada and United Kingdom. B. Martell's co-authors include S J McKenzie, R. V. J. CHARI, Janet L. Gross, W A Blättler, Sandra Cook, Shimul A. Shah, Victor S. Goldmacher, Robert A. Figlin, Thomas E. Hutson and Robert J. Motzer and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer Supplements.

In The Last Decade

B. Martell

6 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Martell United States	5	187	144	142	105	50	6	319
Margreet Lang Netherlands	5	184 1.0×	79 0.5×	134 0.9×	43 0.4×	35 0.7×	7	337
Davide Bosso Italy	12	132 0.7×	57 0.4×	133 0.9×	167 1.6×	70 1.4×	18	366
Alessio Schirone Italy	12	242 1.3×	40 0.3×	124 0.9×	173 1.6×	144 2.9×	22	432
Emily Wearne United States	6	164 0.9×	34 0.2×	159 1.1×	105 1.0×	53 1.1×	6	335
S. Kim United States	7	128 0.7×	50 0.3×	300 2.1×	176 1.7×	87 1.7×	12	436
Natalie Charnley United Kingdom	10	87 0.5×	95 0.7×	69 0.5×	143 1.4×	63 1.3×	32	295
Yann Bergé France	10	162 0.9×	46 0.3×	154 1.1×	100 1.0×	37 0.7×	17	323
B. Newstat United Kingdom	7	460 2.5×	137 1.0×	70 0.5×	175 1.7×	74 1.5×	14	516
Andrée Rorive Belgium	12	197 1.1×	83 0.6×	114 0.8×	107 1.0×	34 0.7×	49	344

Countries citing papers authored by B. Martell

Since Specialization

Citations

This map shows the geographic impact of B. Martell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Martell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Martell more than expected).

Fields of papers citing papers by B. Martell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Martell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Martell. The network helps show where B. Martell may publish in the future.

Co-authorship network of co-authors of B. Martell

This figure shows the co-authorship network connecting the top 25 collaborators of B. Martell. A scholar is included among the top collaborators of B. Martell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Martell. B. Martell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Hutson, Thomas E., Ronald M. Bukowski, Brian I. Rini, et al.. (2014). Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma. British Journal of Cancer. 110(5). 1125–1132. 57 indexed citations

2.

Motzer, Robert J., Thomas E. Hutson, Mark R. Olsen, et al.. (2011). Randomized phase II multicenter study of the efficacy and safety of sunitinib on the 4/2 versus continuous dosing schedule as first-line therapy of metastatic renal cell carcinoma: Renal EFFECT Trial.. Journal of Clinical Oncology. 29(7_suppl). LBA308–LBA308. 31 indexed citations

3.

Hutson, Thomas E., Ronald M. Bukowski, Brian I. Rini, et al.. (2011). A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 29(15_suppl). 4604–4604. 15 indexed citations

4.

Ahlgren, P.D., Michael P. Thirlwell, Ruth O’Regan, et al.. (2009). An open-label study of sunitinib (SU) plus exemestane (E) in the first-line treatment of hormone receptor (HR)-positive metastatic breast cancer (MBC). Journal of Clinical Oncology. 27(15_suppl). e12019–e12019. 2 indexed citations

5.

Barrios, C.H., David Hernández‐Barajas, Michael P. Brown, et al.. (2009). 7122 Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma (mRCC): preliminary results. European Journal of Cancer Supplements. 7(2). 429–430. 6 indexed citations

6.

CHARI, R. V. J., B. Martell, Janet L. Gross, et al.. (1992). Immunoconjugates containing novel maytansinoids: promising anticancer drugs.. PubMed. 52(1). 127–31. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact